These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 26635156)

  • 1. Labetalol in severe and resistant hypertension.
    Williams LC; Murphy MJ; Parsons V
    Br J Clin Pharmacol; 1979 Apr; 8 Suppl 2():143S-7S. PubMed ID: 26635156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Labetalol in severe and resistant hypertension.
    Williams LC; Murphy MJ; Parsons V
    Br J Clin Pharmacol; 1979; 8(Suppl 2):143S-147S. PubMed ID: 526395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Labetalol in resistant hypertension.
    Dargie HJ; Dollery CT; Daniel J
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):751-5. PubMed ID: 990154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics of intravenous labetalol and follow-up therapy with oral labetalol.
    Vlachakis ND; Maronde RF; Maloy JW; Medakovic M; Kassem N
    Clin Pharmacol Ther; 1985 Nov; 38(5):503-8. PubMed ID: 4053487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of isolated systolic hypertension with labetalol in the elderly.
    Giles TD; Weber M; Bartels DW; Silberman HM; Gilderman LP; Burris JF
    Arch Intern Med; 1990 May; 150(5):974-6. PubMed ID: 2184794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute management of severe hypertension with oral labetalol.
    Ghose RR
    Br J Clin Pharmacol; 1979; 8(Suppl 2):189S-193S. PubMed ID: 526400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of labetalol and methyldopa in pregnancy-induced hypertension.
    Lamming GD; Symonds EB
    Br J Clin Pharmacol; 1979 Apr; 8 Suppl 2():217S-22S. PubMed ID: 26635170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of exercise on intra-arterial blood pressure and pulse rate before and during long-term high-dose treatment with labetalol in patients with severe, therapy-resistant hypertension.
    la Cour Petersen E; Kristensen BO
    Postgrad Med J; 1980; 56 Suppl 2():60-4. PubMed ID: 7433345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-hypertensive efficacy of combined alpha- and beta-adrenoreceptor blockade with phentolamine-oxprenolol or with labetalol (AH 5158).
    Johnson BF; LaBrooy J; Munro-Faure AD
    Clin Sci Mol Med Suppl; 1976 Dec; 3():505s-507s. PubMed ID: 799558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of labetalol, a new alpha- and beta-adrenoreceptor blocking drug, on arterial pressure, renal function and renin activity (author's transl)].
    Zech P; Pozet N; Sassard J; Vincent M
    Nouv Presse Med; 1980 Mar; 9(15):1087-90. PubMed ID: 7008020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of labetalol and methyldopa in pregnancy-induced hypertension.
    Lamming GD; Symonds EB
    Br J Clin Pharmacol; 1979; 8(Suppl 2):217S-222S. PubMed ID: 526404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of labetalol in hypertension during exercise and postural changes.
    Balasubramanian V; Mann S; Millar-Craig MW; Raftery EB
    Br J Clin Pharmacol; 1979; 8(Suppl 2):95S-100S. PubMed ID: 526410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute management of severe hypertension with oral labetalol.
    Ghose RR
    Br J Clin Pharmacol; 1979 Apr; 8 Suppl 2():189S-93S. PubMed ID: 26635165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of severe essential hypertension with labetalol: effect on active and inactive renin.
    Hauger-Klevene JH
    Pharmatherapeutica; 1981; 3(1):46-54. PubMed ID: 7033992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous labetalol compared with intravenous nicardipine in the management of hypertension in critically ill patients.
    Malesker MA; Hilleman DE
    J Crit Care; 2012 Oct; 27(5):528.e7-14. PubMed ID: 22300487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of labetalol in hypertension during exercise and postural changes.
    Balasubramanian V; Mann S; Millar-Craig MW; Raftery EB
    Br J Clin Pharmacol; 1979 Apr; 8 Suppl 2():95S-100S. PubMed ID: 26635176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)].
    Martinand A; Lardoux H; Corvol P; Milliez P
    Nouv Presse Med; 1980 Sep; 9(35):2565-8. PubMed ID: 7001349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dilevalol in severe hypertension. A multicenter trial of bolus intravenous dosing.
    Wallin JD; Cook ME; Fletcher E; Holtzman JL; Winer N; Gavras H; Grim CE; Ramanathan KB; Vidt DG; Johnson BF
    Arch Intern Med; 1989 Dec; 149(12):2655-61. PubMed ID: 2688585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hypertension with labetalol.
    Bolli P; Waal-Manning HJ; Simpson FO; Seeman HM
    N Z Med J; 1977 Dec; 86(602):557-63. PubMed ID: 306082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlling hypertension and hypotension immediately post stroke (CHHIPS)--a randomised controlled trial.
    Potter J; Mistri A; Brodie F; Chernova J; Wilson E; Jagger C; James M; Ford G; Robinson T
    Health Technol Assess; 2009 Jan; 13(9):iii, ix-xi, 1-73. PubMed ID: 19208305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.